DARZALEX SC
DARZALEX SC
Approved
DIN Number
02502712
Drug Class
Human
Market Date
Aug 12, 2020
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02502712
AIG Number0158231002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FC01 DARATUMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DARATUMUMABActive
Strength: 1800 MG / 15 ML
Monograph: DARATUMUMAB